Regulations/Policies - Page 18 of 30 - Express Pharma

DoP organises meeting with industry associations to discuss implementation of Phase II PLI scheme

Pfizer applies to US FDA for EUA of its COVID-19 vaccine

Drugs & Cosmetics Act, 1940: Recommendations for a revamp

DCGI asks state drug controllers to recall ulipristal acetate tablets from market

Pfizer files patent infringement petition in US court against Aurobindo, Dr Reddy’s

EMA begins rolling review of Moderna’s COVID-19 vaccine candidate

Industry appreciate Cabinet sanction of Rs 15000 crores for pharma PLI scheme

Lupin’s Somerset facility gets 13 observations post US FDA inspection

NPPA fixes retail price of new-gen rabies vaccine from Cadila Pharma at Rs 681.44

Lasa gets environmental clearance for benzimidazole derivatives capacity expansion at Khed facility